{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T00:40:50Z","timestamp":1792456850964,"version":"4.5.0"},"reference-count":65,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Yeungnam University Research"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Candida albicans is a clinically important fungal pathogen capable of causing both superficial and systemic infections, particularly in immunocompromised individuals. A key factor contributing to its pathogenicity is its ability to form biofilms, structured microbial communities that confer significant resistance to conventional antifungal therapies. Addressing this challenge, we explored the antivirulence potential of acridine derivatives, a class of heterocyclic aromatic compounds known for their diverse biological activities, including antimicrobial, antitumor, and antiparasitic properties. In this study, a series of acridine derivatives was screened against C. albicans biofilms, revealing notable inhibitory activity and highlighting their potential as scaffolds for the development of novel antifungal agents. Among the tested compounds, acridine-4-carboxylic acid demonstrated the most promising activity, significantly inhibiting the biofilm formation at 10 \u00b5g\/mL without affecting planktonic cell growth, and with a minimum inhibitory concentration (MIC) of 60 \u00b5g\/mL. Furthermore, it attenuated filamentation and cell aggregation in a fluconazole-resistant C. albicans strain. Toxicity assessments using Caenorhabditis elegans and plant models supported its low-toxicity profile. These findings highlight the potential of acridine-based scaffolds, particularly acridine-4-carboxylic acid, as lead structures for the development of therapeutics targeting both fungal growth and biofilm formation in Candida albicans infections.<\/jats:p>","DOI":"10.3390\/ijms26157228","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T16:06:17Z","timestamp":1753459577000},"page":"7228","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acridine Derivatives as Antifungal and Antivirulence Agents Against Candida albicans"],"prefix":"10.3390","volume":"26","author":[{"given":"Amra","family":"Yunus","sequence":"first","affiliation":[{"name":"School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluwatosin Oluwaseun","family":"Faleye","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Hyung","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1383-1682","authenticated-orcid":false,"given":"Jintae","family":"Lee","sequence":"additional","affiliation":[{"name":"School of Chemical Engineering, Yeungnam University, Gyeongsan 38541, Republic of Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s12275-011-1064-7","article-title":"Candida albicans, a major human fungal pathogen","volume":"49","author":"Kim","year":"2011","journal-title":"J. Microbiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/jac\/dkad139","article-title":"Invasive candidiasis: Current clinical challenges and unmet needs in adult populations","volume":"78","author":"Soriano","year":"2023","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Parslow, B.Y., and Thornton, C.R. (2022). Continuing shifts in epidemiology and antifungal susceptibility highlight the need for improved disease management of invasive candidiasis. Microorganisms, 10.","DOI":"10.3390\/microorganisms10061208"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Talapko, J., Juzba\u0161i\u0107, M., Matijevi\u0107, T., Pustijanac, E., Beki\u0107, S., Kotris, I., and \u0160krlec, I. (2021). Candida albicans\u2014The virulence factors and clinical manifestations of infection. J. Fungi, 7.","DOI":"10.3390\/jof7020079"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Karajacob, A.S., Azizan, N.B., Al-Maleki, A.R.M., Goh, J.P.E., Loke, M.F., Khor, H.M., Ho, G.F., Ponnampalavanar, S., and Tay, S.T. (2023). Candida species and oral mycobiota of patients clinically diagnosed with oral thrush. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0284043"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"D\u00fchring, S., Germerodt, S., Skerka, C., Zipfel, P.F., Dandekar, T., and Schuster, S. (2015). Host-pathogen interactions between the human innate immune system and Candida albicans\u2014Understanding and modeling defense and evasion strategies. Front. Microbiol., 6.","DOI":"10.3389\/fmicb.2015.00625"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e01658-22","DOI":"10.1128\/spectrum.01658-22","article-title":"Systemic Candida albicans Infection in Mice Causes Endogenous Endophthalmitis via Breaching the Outer Blood-Retinal Barrier","volume":"10","author":"Singh","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1513\/pats.200907-075AL","article-title":"Coping with Candida infections","volume":"7","author":"Evans","year":"2010","journal-title":"Proc. Am. Thorac. Soc."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.arcmed.2005.05.015","article-title":"Invasive candidiasis in immunocompromised hospitalized patients","volume":"36","author":"Sims","year":"2005","journal-title":"Arch. Med. Res."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Priya, A., and Pandian, S.K. (2020). Piperine Impedes Biofilm Formation and Hyphal Morphogenesis of Candida albicans. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00756"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1002\/jobm.201500759","article-title":"Fungal quorum sensing molecules: Role in fungal morphogenesis and pathogenicity","volume":"56","author":"Wongsuk","year":"2016","journal-title":"J. Basic Microbiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1038\/nrmicro3391","article-title":"The BER necessities: The repair of DNA damage in human-adapted bacterial pathogens","volume":"13","author":"Tang","year":"2015","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mib.2019.04.001","article-title":"Candida albicans biofilm growth and dispersal: Contributions to pathogenesis","volume":"52","author":"Wall","year":"2019","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/nrmicro.2017.107","article-title":"Development and regulation of single-and multi-species Candida albicans biofilms","volume":"16","author":"Lohse","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1128\/EC.4.4.633-638.2005","article-title":"Candida biofilms: An update","volume":"4","author":"Ramage","year":"2005","journal-title":"Eukaryot. Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2404256","DOI":"10.1080\/21505594.2024.2404256","article-title":"Antifungal activities of Equol against Candida albicans in vitro and in vivo","volume":"15","author":"Wang","year":"2024","journal-title":"Virulence"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"a019729","DOI":"10.1101\/cshperspect.a019729","article-title":"Fungal biofilms, drug resistance, and recurrent infection","volume":"4","author":"Desai","year":"2014","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"141520","DOI":"10.1016\/j.molstruc.2025.141520","article-title":"Synthesis, molecular docking and anti-biofilm activity of novel benzo[4,5]imidazo[2,1-a]quinazoline, 4H-chromene, and acridine derivatives as potent anti-candida agents","volume":"1331","author":"Sroor","year":"2025","journal-title":"J. Mol. Struct."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11910-018-0865-z","article-title":"Secondary headaches in children and adolescents: What not to miss","volume":"18","author":"Yonker","year":"2018","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1212\/CON.0000000000000252","article-title":"Lyme neuroborreliosis","volume":"21","author":"Marques","year":"2015","journal-title":"Contin. Lifelong Learn. Neurol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.micinf.2016.01.002","article-title":"Candida albicans biofilms: Development, regulation, and molecular mechanisms","volume":"18","author":"Gulati","year":"2016","journal-title":"Microbes Infect."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Ramage, G., Rajendran, R., Sherry, L., and Williams, C. (2012). Fungal biofilm resistance. Int. J. Microbiol., 2012.","DOI":"10.1155\/2012\/528521"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2217\/fmb.13.101","article-title":"Mechanisms of Candida biofilm drug resistance","volume":"8","author":"Taff","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Gabriel, I. (2020). \u2018Acridines\u2019 as new horizons in antifungal treatment. J. Mol., 25.","DOI":"10.3390\/molecules25071480"},{"key":"ref_25","unstructured":"Jalab, M. (2020). The Development of Photo-Activated Antimicrobial Dyes Against Opportunistic Infections. [Ph.D. Thesis, University of Central Lancashire]."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Romo, J.A., Pierce, C.G., Esqueda, M., Hung, C.-Y., Saville, S.P., and Lopez-Ribot, J.L. (2018). In Vitro Characterization of a Biaryl Amide Anti-virulence Compound Targeting Candida albicans Filamentation and Biofilm Formation. Front. Cell. Infect. Microbiol., 8.","DOI":"10.3389\/fcimb.2018.00227"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.mib.2013.06.013","article-title":"Bacterial biofilm development as a multicellular adaptation: Antibiotic resistance and new therapeutic strategies","volume":"16","author":"Reffuveille","year":"2013","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Je\u017eek, J., Hlav\u00e1\u010dek, J., and \u0160ebest\u00edk, J. (2017). Biomedical Applications of Acridines, Springer. XIII, 237.","DOI":"10.1007\/978-3-319-63953-6"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Dudek, A., Szulc, N., Pawlak, A., Struga\u0142a-Danak, P., Krawczyk-\u0141ebek, A., Perz, M., Kostrzewa-Sus\u0142ow, E., and Pruchnik, H. (2024). Structural investigation of interactions between halogenated flavonoids and the lipid membrane along with their role as cytotoxic agents. Sci. Rep., 14.","DOI":"10.1038\/s41598-024-61037-y"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Rz\u0105d, K., Paluszkiewicz, E., and Gabriel, I. (2021). A new 1-nitro-9-aminoacridine derivative targeting yeast topoisomerase II able to overcome fluconazole-resistance. Bioorg. Med. Chem. Lett., 35.","DOI":"10.1016\/j.bmcl.2021.127815"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1128\/MMBR.00020-11","article-title":"Bacterial-fungal interactions: Hyphens between agricultural, clinical, environmental, and food microbiologists","volume":"75","author":"Burlinson","year":"2011","journal-title":"Microbiol. Mol. Biol."},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Abirami, G., Alexpandi, R., Durgadevi, R., Kannappan, A., and Veera Ravi, A. (2020). Inhibitory Effect of Morin Against Candida albicans Pathogenicity and Virulence Factor Production: An in vitro and in vivo Approaches. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.561298"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/EC.05030-11","article-title":"Modulation of morphogenesis in Candida albicans by various small molecules","volume":"10","author":"Shareck","year":"2011","journal-title":"Eukaryot. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Jothi, R., Sangavi, R., Kumar, P., Pandian, S.K., and Gowrishankar, S. (2021). Catechol thwarts virulent dimorphism in Candida albicans and potentiates the antifungal efficacy of azoles and polyenes. Sci. Rep., 11.","DOI":"10.1038\/s41598-021-00485-2"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/08927014.2025.2457151","article-title":"Thiosemicarbazones and analogues as potential biofilm inhibitors of Candida albicans","volume":"41","author":"Barros","year":"2025","journal-title":"Biofouling"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.micres.2017.11.002","article-title":"5-hydroxymethyl-2-furaldehyde from marine bacterium Bacillus subtilis inhibits biofilm and virulence of Candida albicans","volume":"207","author":"Subramenium","year":"2018","journal-title":"Microbiol. Res."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Rajasekharan, S.K., Kamalanathan, C., Ravichandran, V., Ray, A.K., Satish, A.S., and Mohanvel, S.K. (2018). Mannich base limits Candida albicans virulence by inactivating Ras-cAMP-PKA pathway. Sci. Rep., 8.","DOI":"10.1038\/s41598-018-32935-9"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Atriwal, T., Azeem, K., Husain, F.M., Hussain, A., Khan, M.N., Alajmi, M.F., and Abid, M. (2021). Mechanistic understanding of Candida albicans biofilm formation and approaches for its inhibition. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.638609"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Gupta, P., Pruthi, P.A., and Pruthi, V. (2019). Role of exopolysaccharides in biofilm formation. Introduction to Biofilm Engineering, ACS Publications.","DOI":"10.1021\/bk-2019-1323.ch002"},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Cavalheiro, M., and Teixeira, M.C. (2018). Candida biofilms: Threats, challenges, and promising strategies. Front. Med., 5.","DOI":"10.3389\/fmed.2018.00028"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Pierce, C.G., Chaturvedi, A.K., Lazzell, A.L., Powell, A.T., Saville, S.P., McHardy, S.F., and Lopez-Ribot, J.L. (2015). A novel small molecule inhibitor of Candida albicans biofilm formation, filamentation and virulence with low potential for the development of resistance. npj Biofilms Microbiomes, 1.","DOI":"10.1038\/npjbiofilms.2015.12"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Sharma, J., Rosiana, S., Razzaq, I., and Shapiro, R.S. (2019). Linking cellular morphogenesis with antifungal treatment and susceptibility in Candida pathogens. J. Fungi, 5.","DOI":"10.3390\/jof5010017"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S1383-5718(99)00112-6","article-title":"Genotoxicity assessment of new synthesized acridine derivative\u20143,6-diamino-10-methyl-9, 10-dihydroacridine","volume":"444","author":"Ferenc","year":"1999","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Hsu, K.-H., Su, B.-H., Tu, Y.-S., Lin, O.A., and Tseng, Y.J. (2016). Mutagenicity in a molecule: Identification of core structural features of mutagenicity using a scaffold analysis. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0148900"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mrgentox.2007.10.022","article-title":"DNA-damaging activity and mutagenicity of 16 newly synthesized thiazolo[5,4-a]acridine derivatives with high photo-inducible cytotoxicity","volume":"650","author":"Nikoyan","year":"2008","journal-title":"Mutat. Res. Genet. Toxicol. Environ. Mutagen."},{"key":"ref_46","unstructured":"PubChem (2025, July 10). Compound Summary for CID 11138739, Acridine-4-Carboxylic Acid. PubChem, Available online: https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/Acridine-4-carboxylic-Acid."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Denny, W.A. (2002). Acridine-4-carboxamides and the concept of minimal DNA intercalators. Small Molecule DNA\/RNA Binders: From Synthesis to Nucleic Acid Complexes, Wiley.","DOI":"10.1002\/3527601783.ch18"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"5226","DOI":"10.2174\/0109298673310987240610091522","article-title":"An overview of acridine analogs: Pharmacological significance and recent developments","volume":"32","author":"Sabarees","year":"2025","journal-title":"Curr. Med. Chem."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"83","DOI":"10.5937\/KgJSci1840083R","article-title":"A review of published data on acridine derivatives with different biological activities","volume":"40","author":"Rupar","year":"2018","journal-title":"Kragujev. J. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0009-2797(96)03754-4","article-title":"In vitro DNA crosslinking by Ledakrin, an antitumor derivative of 1-nitro-9-aminoacridine","volume":"103","author":"Bartoszek","year":"1997","journal-title":"Chem. Biol. Interact."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jare.2014.11.002","article-title":"A mini review on pyridoacridines: Prospective lead compounds in medicinal chemistry","volume":"6","author":"Sharma","year":"2015","journal-title":"J. Adv. Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ddtec.2004.11.007","article-title":"Lead-and drug-like compounds: The rule-of-five revolution","volume":"1","author":"Lipinski","year":"2004","journal-title":"Drug Discov. Today Technol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Sousa, G., de Almeida, M.C., L\u00f3cio, L.L., Santos, V.L.d., Bezerra, D.P., Silva, V.R., Almeida, S., Simon, A., Hon\u00f3rio, T.d.S., and Cabral, L.M. (2022). Synthesis and evaluation of antiproliferative activity, topoisomerase II inhibition, DNA binding and non-clinical toxicity of new acridine\u2013thiosemicarbazone derivatives. Pharmaceuticals, 15.","DOI":"10.3390\/ph15091098"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3201\/eid2302.161320","article-title":"Biofilm-forming capability of highly virulent, multidrug-resistant Candida auris","volume":"23","author":"Sherry","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Aydin, M., Unusan, N., Sumlu, E., and Korucu, E.N. (2024). Rosmarinic acid exhibits antifungal and antibiofilm activities against Candida albicans: Insights into gene expression and morphological changes. J. Fungi, 10.","DOI":"10.3390\/jof10110751"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1021\/acsinfecdis.9b00033","article-title":"Inhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin via hyphal-growth suppression","volume":"5","author":"Lee","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"ref_58","unstructured":"Wayne, P. (2020). Clinical and laboratory Standards Institute (CLSI) (2020) Performance standards for antimicrobial susceptibility testing: Background, Organization, Functions, and Processes. J. Clin. Microbiol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10534-025-00678-6","article-title":"Comparative evaluation of biologically and chemically synthesized zinc oxide nanoparticles for preventing Candida auris biofilm","volume":"38","author":"Fayed","year":"2025","journal-title":"Biometals"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Sharifi, A., Mohammadzadeh, A., Salehi, T.Z., Mahmoodi, P., and Nourian, A. (2021). Cuminum cyminum L. essential oil: A promising antibacterial and antivirulence agent against multidrug-resistant Staphylococcus aureus. Front. Microbiol., 12.","DOI":"10.3389\/fmicb.2021.667833"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/ncomms1685","article-title":"Sensing of mammalian IL-17A regulates fungal adaptation and virulence","volume":"3","author":"Zelante","year":"2012","journal-title":"Nat. Commun."},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Sathiyamoorthi, E., Faleye, O.S., Lee, J.-H., and Lee, J. (2023). Hydroquinone derivatives attenuate biofilm formation and virulence factor production in Vibrio spp. Int. J. Food Microbiol., 384.","DOI":"10.1016\/j.ijfoodmicro.2022.109954"},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Bezerra Filho, C.M., da Silva, L.C.N., da Silva, M.V., L\u00f8bner-Olesen, A., Struve, C., Krogfelt, K.A., Correia, M.T.d.S., and Vilela Oliva, M.L. (2020). Antimicrobial and Antivirulence Action of Eugenia brejoensis Essential Oil in vitro and in vivo Invertebrate Models. Front. Microbiol., 11.","DOI":"10.3389\/fmicb.2020.00424"},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Zarroug, S.H., Bajaman, J.S., Hamza, F.N., Saleem, R.A., and Abdalla, H.K. (2023). Caenorhabditis elegans as an in vivo model for the discovery and development of natural plant-based antimicrobial compounds. Pharmaceuticals, 16.","DOI":"10.3390\/ph16081070"},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Dulsat, J., L\u00f3pez-Nieto, B., Estrada-Tejedor, R., and Borrell, J.I. (2023). Evaluation of free online ADMET tools for academic or small biotech environments. Molecules, 28.","DOI":"10.3390\/molecules28020776"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7228\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:16:24Z","timestamp":1760033784000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":65,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157228"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157228","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]}}}